"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
20
SWOG Cancer Research Network
9
Alliance for Clinical Trials in Oncology
8
ECOG-ACRIN Cancer Research Group
3
NRG Oncology
2
Wake Forest University Health Sciences
2
Clinical Trials at Aspirus Medford Hospital
During the past decade, Aspirus Medford Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 4 clinical trials were completed, i.e. on
average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8%
of trials that started reached the finish line.
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Aspirus Medford Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "SWOG Cancer Research Network" with 9 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Medford Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Aspirus Medford Hospital
According to Clinical.Site data, the most researched conditions in "Aspirus Medford Hospital" are
"Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Aspirus Medford Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Aspirus Medford Hospital
Most popular intervention types in "Aspirus Medford Hospital" are "Drug" (34 trials), "Other" (27 trials), "Biological" (20 trials), "Procedure" (20 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Biospecimen Collection" (13 trials), "Computed Tomography" (13 trials), "Questionnaire Administration" (11 trials) and "Magnetic Resonance Imaging" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Aspirus Medford Hospital
The vast majority of trials in "Aspirus Medford Hospital" are
41 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Aspirus Medford Hospital
Currently, there are NaN active trials in "Aspirus Medford Hospital".
undefined are not yet recruiting,
21 are recruiting,
20 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Aspirus Medford Hospital,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Aspirus Medford Hospital, 0 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 27 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".